8. Income Taxes

The provision for income taxes consisted of the following for the periods presented:

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

Current provision (benefit)

 

 

 

 

 

 

 

 

 

Federal

 

$

(9

)

 

$

324

 

 

$

(14

)

State

 

 

1,989

 

 

 

2,020

 

 

 

4,788

 

Total current provision

 

 

1,980

 

 

 

2,344

 

 

 

4,774

 

Deferred provision (benefit)

 

 

 

 

 

 

 

 

 

Federal

 

 

32,090

 

 

 

27,791

 

 

 

19,505

 

State

 

 

3,689

 

 

 

2,293

 

 

 

(1,368

)

Total deferred provision

 

 

35,779

 

 

 

30,084

 

 

 

18,137

 

Total provision

 

$

37,759

 

 

$

32,428

 

 

$

22,911

 

 

A reconciliation of the statutory income tax rate and provision to our effective tax rate and total tax provision consisted of the following for the periods presented:

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

 

Amount

 

 

Percent

 

 

Amount

 

 

Percent

 

 

Amount

 

 

Percent

 

Income tax provision at the statutory rate

$

29,575

 

 

 

21.0

%

 

$

21,560

 

 

 

21.0

%

 

$

21,639

 

 

 

21.0

%

State income taxes, net of federal benefit

 

5,221

 

 

 

3.7

%

 

 

3,646

 

 

 

3.6

%

 

 

2,359

 

 

 

2.3

%

Tax credits

 

(399

)

 

 

-0.3

%

 

 

(227

)

 

 

-0.2

%

 

 

(487

)

 

 

-0.5

%

Nontaxable or nondeductible items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share-based payment awards

 

2,963

 

 

 

2.1

%

 

 

6,702

 

 

 

6.5

%

 

 

(1,431

)

 

 

-1.4

%

Other

 

313

 

 

 

0.2

%

 

 

410

 

 

 

0.4

%

 

 

84

 

 

 

0.1

%

Changes in unrecognized tax benefits

 

82

 

 

 

0.1

%

 

 

478

 

 

 

0.5

%

 

 

-

 

 

 

0.0

%

Other

 

4

 

 

 

0.0

%

 

 

(140

)

 

 

-0.1

%

 

 

748

 

 

 

0.7

%

Effective tax rate

$

37,759

 

 

 

26.8

%

 

$

32,428

 

 

 

31.6

%

 

$

22,911

 

 

 

22.2

%

The income tax expense recorded in 2025 is different from the expected statutory federal and state tax expense primarily due to a $2,963 income tax expense related to equity award exercises and/or vesting in 2025, which is net of the impact of the internal revenue code rules and regulations related to the deductibility of executive compensation by publicly held companies.

 

 

As of

 

 

 

December 31, 2025

 

 

December 31, 2024

 

Deferred tax assets

 

 

 

 

 

 

Lease liability

 

$

240,652

 

 

$

234,108

 

Stock based compensation

 

 

10,360

 

 

 

12,915

 

Accrued compensation costs

 

 

1,798

 

 

 

1,710

 

Deferred revenue

 

 

931

 

 

 

1,211

 

Net operating loss carryforwards

 

 

26,932

 

 

 

16,929

 

Interest expense carryforwards

 

 

30,682

 

 

 

38,578

 

Business tax credit carryforwards, net

 

 

3,766

 

 

 

3,285

 

Other

 

 

3,080

 

 

 

3,598

 

Gross deferred tax assets

 

 

318,201

 

 

 

312,334

 

Valuation allowance

 

 

(290

)

 

 

(262

)

Net deferred tax assets

 

 

317,911

 

 

 

312,072

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

 

 

 

 

ROU assets

 

 

(235,821

)

 

 

(230,018

)

Goodwill and other intangible assets

 

 

(89,690

)

 

 

(77,040

)

Property and equipment

 

 

(129,449

)

 

 

(106,083

)

Other

 

 

(498

)

 

 

(672

)

Gross deferred tax liabilities

 

 

(455,458

)

 

 

(413,813

)

Total deferred tax liabilities, net

 

$

(137,547

)

 

$

(101,741

)

We had federal and state net operating loss (“NOL”) carryforwards available of $108,915 and $85,218 at December 31, 2025, respectively. The federal NOL carryforwards can be carried forward indefinitely while $38,889 of the state NOL carryforwards have indefinite lives and the remaining amounts will expire between 2036 and 2043. We had federal interest expense carryforwards of $108,357 at December 31, 2025

, which can be carried forward indefinitely. We also had state interest expense carryforwards in 12 states where the amounts vary by jurisdiction, which also have indefinite lives. We had federal and state R&D and other business tax credit carryforwards of $3,283 and $1,119 at December 31, 2025, respectively. The federal business tax credit carryforwards can be carried forward for 20 years and will expire between 2039 and 2045. The state R&D and other business tax credit carryforwards can be carried forward for 5 to 20 years and will expire between 2029 and 2038.

As noted above, we had deferred tax assets related to both federal and state NOL and interest expense carryforwards. When determining the need for a valuation allowance, we consider all available positive and negative evidence, including taxable income in prior carryback years (if carryback is permitted under the relevant tax law), the timing of the reversal of existing taxable temporary differences, tax planning strategies and projected future taxable income. We adjust the valuation allowance in the period management determines it is more likely than not that we will not realize some or all of the deferred tax assets.

For financial reporting purposes, we established valuation allowances of $290 and $262 at December 31, 2025 and 2024, respectively, to offset deferred tax assets. The current and prior year valuation allowance relates to state attributes and carryovers.

On July 4, 2025, the “One Big Beautiful Bill Act” (the “OBBBA”) was signed into law. The OBBBA includes tax reform provisions including 100% bonus depreciation, full expensing of domestic research expenditures, and modifications to interest expense limitations. After initial evaluation, the Company does not currently expect these laws to have a material effect on tax expense or the anticipated annual effective tax rate. We expect certain provisions effective for the 2025 tax year will decrease current and future cash taxes paid on the consolidated financial statements.

Past ownership changes and other equity transactions may have triggered Sections 382 and 383 of the Internal Revenue Code, resulting in certain annual limitations on the utilization of existing federal and state net operating losses and credits. Such provisions may limit the potential future tax benefit to be realized by us from its accumulated net operating losses and tax credit carryforwards.

We file income tax returns in the U.S. federal and various state tax jurisdictions and are subject to varying statutes of limitation in each jurisdiction. As of December 31, 2025, we are not under audit for federal or state income tax purposes. In general, our federal tax return may be subject to examination for the 2022 through 2024 tax years, while for state purposes, the 2021 through 2024 years are generally open to examination, with some states having either a three- or four-year statute of limitations. Our usage of NOL carryovers also permits taxing authorities to adjust aspects of tax returns that may be outside of these statutes of limitation.

A table of income taxes paid is as follows:

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Federal

$

79

 

 

$

-

 

 

$

(161

)

State

 

 

 

 

 

 

 

 

Arizona

(a)

 

 

 

97

 

 

(a)

 

Florida

 

76

 

 

(a)

 

 

 

1,401

 

Georgia

(a)

 

 

(a)

 

 

 

205

 

Idaho

 

44

 

 

 

52

 

 

(a)

 

Michigan

 

245

 

 

 

236

 

 

 

210

 

Minnesota

(a)

 

 

 

325

 

 

 

504

 

Pennsylvania

(a)

 

 

 

116

 

 

(a)

 

Texas

 

1,127

 

 

 

987

 

 

 

879

 

Other

 

(740

)

 

 

(951

)

 

 

218

 

Total State

 

752

 

 

 

862

 

 

 

3,417

 

Cash paid for income taxes, net of refunds

$

831

 

 

$

862

 

 

$

3,256

 

(a)
The amount of income taxes paid during the year does not meet the 5% disaggregation threshold and is included in 'Other'.

A reconciliation of the beginning and ending amounts of gross unrecognized tax benefits is as follows:

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Tax contingencies at beginning of period

$

542

 

 

$

-

 

 

$

-

 

Additions based on tax positions related to the current year

 

95

 

 

 

83

 

 

 

-

 

Additions based on tax positions related to prior years

 

-

 

 

 

459

 

 

 

-

 

Tax contingencies at end of period

$

637

 

 

$

542

 

 

$

-

 

 

We had gross unrecognized tax benefits of $637 and $542 as of December 31, 2025 and 2024, respectively, related to federal and state R&D tax credits. All of the unrecognized tax benefits, if recognized, would affect the effective tax rate.

We accrued interest and penalties of $12 and $42 as of December 31, 2025 and 2024, respectively, in income tax expense.

Historical Timeline

Fiscal YearFiled
2025Feb 27, 2026Showing above
2024Feb 21, 2025
2023Feb 23, 2024
2022Feb 24, 2023
2021Mar 25, 2022

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.